🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
A randomized, double-blind, placebo-controlled study to assess the effect o...
Status
Unknown
Location
Shourya clinic
Start Date
2024-07-25
Trial ID
NCT06496893
Treatments Being Tested
Much has been learned about the efficacy and effectiveness of comprehensive...
Status
Unknown
Location
South Texas Rural Health Services Clinic
Start Date
2017-11-01
Trial ID
NCT03186885
This research study is studying the combination of anakinra and axicabtagen...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-10-01
Trial ID
NCT04150913
Treatments Being Tested
The purpose of this study was to describe the nicotine pharmacokinetic (PK)...
Status
Completed
Location
Celerion
Start Date
2023-02-16
Trial ID
NCT05789420
The goal of this Phase I clinical trial is to evaluate how the imaging drug...
Status
Recruiting
Location
Excel Diagnostics & Nuclear Oncology Center
Start Date
2026-08-15
Trial ID
NCT07733674
Treatments Being Tested
This is a single-arm, phase II study aiming to evaluate the feasibility and...
Status
Unknown
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Start Date
2019-05-01
Trial ID
NCT04267549
Treatments Being Tested
Indication: Patients who were diagnosed with Parkinson's disease ≥ 5 years ...
Status
Completed
Location
Yonsei University Health System, Severance Hospital
Start Date
2023-05-09
Trial ID
NCT05887466
This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Status
Completed
Location
Research Facility
Start Date
2017-09-07
Trial ID
NCT02963831
Treatments Being Tested